Deutsche Bank Downgrades Mednax (MD) to Sell; Real Risk

July 18, 2012 7:00 AM EDT Send to a Friend
Get Alerts MD Hot Sheet
Price: $92.27 -0.23%

Rating Summary:
    8 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 12 | New: 30
Trade MD Now!
Deutsche Bank downgraded Mednax (NYSE: MD) from Hold to Sell with a price target of $58.00 (from $73.00).

Deutsche analyst said, "We believe the investment case on MD could be challenged over the next 12 months against a backdrop of policy initiatives to reduce NICU utilization. Empirical evidence of NICU pressure is beginning to surface, yet we believe industry and government initiatives are accelerating in a manner that are
likely to challenge MD's base business."

Sees 2013 Street estimates as too high, trading multiple could slip.

For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.

Shares of Mednax closed at $66.74 yesterday, with a 52 week range of $58.48-$75.86.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst PT Change, Downgrades

Related Entities

Deutsche Bank

Add Your Comment